These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 2864532

  • 21. The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis.
    Riis BJ, Rødbro P, Christiansen C.
    Calcif Tissue Int; 1986 Jun; 38(6):318-22. PubMed ID: 3089552
    [Abstract] [Full Text] [Related]

  • 22. Physiologic and pharmacologic effects of estrogen and progestins on bone.
    DeCherney A.
    J Reprod Med; 1993 Dec; 38(12 Suppl):1007-14. PubMed ID: 8120857
    [Abstract] [Full Text] [Related]

  • 23. Hydroxyproline/creatinine ratios as estimates of bone resorption in early postmenopausal women. Fasting and 24-h urine samples compared.
    Pødenphant J, Riis BJ, Larsen NE, Christiansen C.
    Scand J Clin Lab Invest; 1986 Sep; 46(5):459-63. PubMed ID: 3529351
    [Abstract] [Full Text] [Related]

  • 24. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M, Theppisai U, Manonai J, Suchartwatnachai C, Jorgensen LN.
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [Abstract] [Full Text] [Related]

  • 25. Scanning electron microscopy of the effect of short-term hormonal therapy on postmenopausal endometrium.
    Nathan E, Knoth M, Nilsson BO.
    Ups J Med Sci; 1978 Sep; 83(3):175-83. PubMed ID: 715950
    [No Abstract] [Full Text] [Related]

  • 26. The effect of calcium supplements on plasma alkaline phosphatase and urinary hydroxyproline in postmenopausal women.
    Horowitz M, Need AG, Philcox JC, Nordin BE.
    Horm Metab Res; 1985 Jun; 17(6):311-2. PubMed ID: 4018720
    [Abstract] [Full Text] [Related]

  • 27. Estrogen plus a progestin for prevention of postmenopausal osteoporosis.
    Med Lett Drugs Ther; 1985 Oct 25; 27(699):91-2. PubMed ID: 3903458
    [No Abstract] [Full Text] [Related]

  • 28. [Current research in therapy of postmenopausal osteoporosis (author's transl)].
    Laroche C, Detilleux M, Sereni D.
    Sem Hop; 1985 Oct 25; 55(7-8):325-9. PubMed ID: 220722
    [Abstract] [Full Text] [Related]

  • 29. Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women.
    Johansen JS, Riis BJ, Delmas PD, Christiansen C.
    Eur J Clin Invest; 1988 Apr 25; 18(2):191-5. PubMed ID: 2968266
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Time-dependent variations in bone turnover parameters during 2 months' cyclic treatment with different doses of combined estrogen and progestogen in postmenopausal women.
    Johansen JS, Jensen SB, Riis BJ, Christiansen C.
    Metabolism; 1990 Nov 25; 39(11):1122-6. PubMed ID: 2233271
    [Abstract] [Full Text] [Related]

  • 34. Sex steroids and osteoporosis: effects of deficiencies and substitutive treatments.
    Schot LP, Schuurs AH.
    J Steroid Biochem Mol Biol; 1990 Oct 25; 37(2):167-82. PubMed ID: 2268549
    [Abstract] [Full Text] [Related]

  • 35. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M.
    Ther Umsch; 2000 Oct 25; 57(10):628-34. PubMed ID: 11081374
    [Abstract] [Full Text] [Related]

  • 36. Mechanisms underlying the effects of phosphate and calcitonin on bone histology in postmenopausal osteoporosis.
    Marie PJ, Caulin F.
    Bone; 1986 Oct 25; 7(1):17-22. PubMed ID: 3964494
    [Abstract] [Full Text] [Related]

  • 37. Does 1,25(OH)2D3 accelerate spinal bone loss? A controlled therapeutic trial in 70-year-old women.
    Jensen GF, Meinecke B, Boesen J, Transbøl I.
    Clin Orthop Relat Res; 1985 Oct 25; (192):215-21. PubMed ID: 3881203
    [Abstract] [Full Text] [Related]

  • 38. Post-menopausal bone loss: effects of oestrogens and progestogens. A review.
    Riis BJ, Christiansen C.
    Maturitas; 1986 Dec 25; 8(4):267-74. PubMed ID: 3553863
    [No Abstract] [Full Text] [Related]

  • 39. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
    Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F.
    J Bone Miner Res; 2002 Oct 25; 17(10):1904-12. PubMed ID: 12369794
    [Abstract] [Full Text] [Related]

  • 40. Clinical significance and pathogenesis of osteoporosis.
    Nordin BE.
    Br Med J; 1971 Mar 13; 1(5749):571-6. PubMed ID: 5548297
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.